Developer docs
API playgroundTry for free, no card

Search company profiles

IgA Nephropathy Foundation

Full company profile

uuid000ni7a

Namestring
IgA Nephropathy Foundation
Legal namestring
IgA Nephropathy Foundation
Websiteurl
igan.org
Company typeenum
Private
Founded yearint
2006
Descriptiontext

The IgA Nephropathy Foundation is a 501(c)(3) nonprofit patient advocacy organization founded in 2004 and headquartered in Wall Township, New Jersey, dedicated to finding a cure for IgA Nephropathy (IgAN), a rare autoimmune glomerular kidney disease that is the most common primary glomerular disease worldwide and progresses to end-stage kidney disease in 20–40% of patients. Co-founded by Executive Director Bonnie Schneider, the Foundation serves IgAN patients across the disease continuum, their caregivers and family members, nephrologists and other healthcare providers, and patient advocates. Its programs are organized around four pillars: research, education, support, and advocacy.

Its core product and research asset is the IgAN Hope Patient Registry, a HIPAA-compliant global registry launched in July 2025 at SPARK Chicago that captures diagnosis, treatment, lab values, quality-of-life, dietary, and mental-health data, with optional EHR integration. Surrounding products include the IgAN+ mobile application for iOS and Android, the IgAN Care nephrology provider finder, the IgAN Cookbook and recipe library, a Clinical Trials Directory, an HCP Library for clinician education, and a Patient Aid financial-assistance program. Community infrastructure is delivered through the SPARK annual patient conference, the IgAN Ambassador Program, the Go Global Network for international audiences, the Asian IgAN Awareness Initiative, and structured support groups. Content is distributed via blog, email newsletter, Facebook, X/Twitter, Instagram, YouTube, in-person Hill Days on Capitol Hill, and recognition-anchored appearances at ASN Kidney Week.

The Foundation operates a donation-and-sponsorship revenue model without commercial pricing. Income is generated from individual donations processed through NeonCRM, event- and community-led fundraising (including ambassador-hosted restaurant nights), membership enrollment, and corporate sponsorship from pharmaceutical companies developing IgAN therapies—Vertex Pharmaceuticals (Emerald sponsor for Kidney Month 2026), Calliditas Therapeutics (Friend sponsor), Novartis, Vera Therapeutics, and Takeda Pharmaceuticals (Emerging Therapies Forum). Additional programmatic funding has come from the Chan Zuckerberg Initiative, which underwrote the Foundation's first research poster at ASN Kidney Week 2025. No revenue is earned from program participants; all patient-facing services are free of charge.

Short descriptiontext

The IgA Nephropathy Foundation is a 501(c)(3) nonprofit that provides education, support, advocacy, and a global patient registry for individuals affected by IgA Nephropathy, a rare autoimmune kidney disease, and their caregivers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTownship Of Washington, United States
HQ citystring
Township Of Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease advocacy, kidney disease support, patient education resources, nephrology community programs, patient registry research
Industry2 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Other Individual and Family Services624190
SIC code1 code
  • Services-Social Services8300
Product category
Rare Disease Patient Advocacy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Donations and Fundraising
TypeOthers
Description

The Foundation generates revenue primarily through donations from individuals, corporate sponsors, and fundraising campaigns. This includes direct donations via its website portal (igan.app.neoncrm.com), event-based fundraising, and community-driven initiatives such as restaurant fundraisers hosted by patient ambassadors.

igan.org
2Corporate Sponsorship
TypeOthers
Description

Pharmaceutical companies and healthcare organizations sponsor Foundation programs, events, and campaigns. Sponsorship tiers include Emerald, Friend, and other levels. Sponsors include Vertex Pharmaceuticals (Emerald), Calliditas Therapeutics (Friend), Novartis, Vera Therapeutics, and Takeda Pharmaceuticals.

igan.org
3Membership Dues
TypeSubscription Recurring
Description

The Foundation offers membership enrollment, suggesting membership-based support. Membership provides access to resources, community, and advocacy tools.

igan.org
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Operations, Technology or R&D, Others
Pricing details1 tier
1Patient Registry access is free for patients
ModelFreemiumBilling cadencePay-as-you-go
Notes

The IgAN Hope Patient Registry is free to join for all patients diagnosed with IgA Nephropathy or IgA Vasculitis. Participation is voluntary and HIPAA-compliant.

igan.org
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1IgAN Hope Patient Registry
Description

A global registry for individuals with IgA Nephropathy and IgA Vasculitis to drive research, accelerate treatments, and improve patient outcomes.

igan.org
+4 more records
Core offering1 text field

The IgA Nephropathy Foundation is a 501(c)(3) nonprofit patient advocacy organization that delivers education, support, research, and advocacy resources to individuals affected by IgA Nephropathy, a rare autoimmune kidney disease. Its offerings include the IgAN Hope Patient Registry, the IgAN+ mobile app, the SPARK annual conference, the IgAN Care provider finder, nutrition and recipe resources, ambassador and caregiver programs, and federal legislative advocacy. All programs are provided free of charge to patients and caregivers and funded primarily through donations and corporate sponsorships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 20-40% of IgAN patients develop end-stage kidney disease requiring dialysis or transplant
+2 more records
Product overview1 text field

The IgA Nephropathy Foundation offers a portfolio of patient-focused programs and resources organized around four pillars: education, support, research, and advocacy. The central product is the IgAN Hope Patient Registry—a global database enabling patients with IgA Nephropathy and IgA Vasculitis to contribute health data, connect Electronic Health Records, and support research acceleration. This connects to the Foundation's digital ecosystem: the IgAN+ mobile app (iOS/Android) for patient self-management, the IgAN Cookbook and recipe library for kidney-friendly nutrition, the IgAN Care nephrology provider finder, and the IgAN Risk Quiz for awareness. Community and advocacy are served through the IgAN Ambassador Program, the IgAN Go Global Network for international reach, the annual SPARK Conference for patient education, IgA Nephropathy Day and Kidney Health + Nutrition Month awareness campaigns, and a Patient Aid financial assistance program. Research infrastructure includes a Clinical Trials Directory, an HCP Library for healthcare professional education, and published research articles. The portfolio is completed by Faces of IgAN storytelling, mental health resources, pregnancy and family planning guides, caregiver support, and an IgAN FAQ.

Product and service6 records
1IgAN Hope Patient Registry
CategoryPatient Registry / Research Platform
Description

A global, HIPAA-compliant patient registry for individuals with IgA Nephropathy and IgA Vasculitis. Participants contribute anonymized health data including diagnosis, symptoms, treatments, lab values, quality of life, diet, and mental health information, and can connect their Electronic Health Record. The registry drives research and accelerates treatment development.

2IgAN+ Mobile App
CategoryPatient Self-Management Mobile App
Description

Mobile application for IgAN patients providing nutrition guides, kidney-friendly recipes, self-management tools, and community resources. Available on iOS and Android via the Foundation's app pages.

3SPARK Conference
CategoryPatient Conference / Educational Event
Description

The only conference dedicated exclusively to IgA Nephropathy patients and their caregivers, featuring education, research updates, and community connection. Annual event with registration managed through the dedicated SPARK website.

4IgANCare Provider Finder
CategoryProvider Directory / Referral Service
Description

A nephrology provider finder that allows IgAN patients to locate healthcare providers specialized in their disease. Patients can also encourage their provider to join or nominate a provider for inclusion in the network.

5IgAN Cookbook
CategoryNutrition / Cookbook Resource
Description

Kidney-friendly recipe collection providing meals tailored for individuals managing IgA Nephropathy, with emphasis on low-sodium, low-potassium, and kidney-healthy ingredients. Developed in partnership with Cukebook (Culinary Nutrition for Kidneys, Inc.).

6IgAN Risk Quiz
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-12-01
Description

The Pittsburgh Steelers partnered with the IgAN Foundation and Hayden Shock (kidney transplant recipient) to support the '13 for LIFE' organ donation awareness campaign on Capitol Hill, raising awareness about the organ shortage affecting over 103,000 people in the U.S.

2Cukebook (Culinary Nutrition for Kidneys, Inc.)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Cukebook, a nutrition-forward nonprofit backed by 501c3 Culinary Nutrition for Kidneys, Inc., provides recipes, guides, and nutrition tools for people living with chronic kidney disease. The Foundation's recipe section and nutrition content extensively features Cukebook resources, with Lauren Levy serving as both a Foundation contributor and Director at Cukebook.

igan.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

ASN hosts Kidney Week, at which the Foundation presents research, delivers lectureships, and hosts forums. The Foundation's Bonnie Schneider delivered the Celeste Castillo Lee Endowed Lectureship at ASN Kidney Week 2025.

Strategic tierMinorTypeGTM or Marketing Partner
Description

The Foundation participates in Rare Disease Day (hosted by rarediseases.org) to raise awareness for IgA Nephropathy as a rare kidney disease.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1NephCure Kidney International
TypeDirect peer
Description

Rare kidney disease-focused nonprofit historically centered on nephrotic syndrome and FSGS but expanding to include IgAN. Closest direct peer in mission, structure, and patient registry focus.

TypeBroad incumbent
Description

The largest U.S. kidney disease nonprofit, funding research, patient education, and advocacy across all kidney conditions including IgAN. Highly comparable as a patient-advocacy peer but operates at a much broader scale and lacks IgAN-specific focus.

TypeBroad incumbent
Description

National nonprofit providing financial assistance, education, and advocacy for kidney patients. Directly comparable in mission (patient aid, education, advocacy) and overlapping disease scope, though much larger and not IgAN-focused.

TypeDirect peer
Description

Patient advocacy organization for polycystic kidney disease, another rare genetic kidney disease. Closely comparable as a disease-specific kidney nonprofit operating a patient registry, research grants, and conferences.

TypeDirect peer
Description

Rare hereditary kidney disease foundation providing patient education, community support, and research advocacy. Highly comparable small-team, patient-led structure and mission to accelerate treatments for a rare kidney condition.

TypeBroad incumbent
Description

Independent kidney patient organization focused on advocacy, education, and patient engagement across kidney diseases. Comparable as a kidney-specific patient advocacy peer, including Hill Day-style advocacy and patient ambassadorship.

TypeBroad incumbent
Description

Umbrella rare disease advocacy organization that supports patient organizations including IgAN-focused foundations. Highly comparable advocacy mission and patient community focus, but operates at a much larger scale across all rare diseases.

TypeBroad incumbent
Description

Rare disease policy and advocacy nonprofit advancing legislative and regulatory issues for rare disease patient communities. Comparable advocacy focus, particularly around federal policy work that complements the IgAN Foundation's Hill Day efforts.

9CureGN (Cure Glomerulonephropathy Network)
TypeOthers
Description

Multi-center NIH-funded research consortium studying glomerular diseases including IgAN. Comparable registry/research mission and serves as both a potential research partner and indirect peer for patient data infrastructure.

TypeOthers
Description

Public-private partnership between ASN and FDA focused on kidney disease innovation. Comparable as a research/advocacy ecosystem stakeholder and the Foundation collaborates with it through ASN Kidney Week.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IgA Nephropathy Foundation

Rare Disease Patient Advocacyigan.org

The IgA Nephropathy Foundation is a 501(c)(3) nonprofit that provides education, support, advocacy, and a global patient registry for individuals affected by IgA Nephropathy, a rare autoimmune kidney disease, and their caregivers.

What IgA Nephropathy Foundation does

The IgA Nephropathy Foundation is a 501(c)(3) nonprofit patient advocacy organization founded in 2004 and headquartered in Wall Township, New Jersey, dedicated to finding a cure for IgA Nephropathy (IgAN), a rare autoimmune glomerular kidney disease that is the most common primary glomerular disease worldwide and progresses to end-stage kidney disease in 20–40% of patients. Co-founded by Executive Director Bonnie Schneider, the Foundation serves IgAN patients across the disease continuum, their caregivers and family members, nephrologists and other healthcare providers, and patient advocates. Its programs are organized around four pillars: research, education, support, and advocacy.

Its core product and research asset is the IgAN Hope Patient Registry, a HIPAA-compliant global registry launched in July 2025 at SPARK Chicago that captures diagnosis, treatment, lab values, quality-of-life, dietary, and mental-health data, with optional EHR integration. Surrounding products include the IgAN+ mobile application for iOS and Android, the IgAN Care nephrology provider finder, the IgAN Cookbook and recipe library, a Clinical Trials Directory, an HCP Library for clinician education, and a Patient Aid financial-assistance program. Community infrastructure is delivered through the SPARK annual patient conference, the IgAN Ambassador Program, the Go Global Network for international audiences, the Asian IgAN Awareness Initiative, and structured support groups. Content is distributed via blog, email newsletter, Facebook, X/Twitter, Instagram, YouTube, in-person Hill Days on Capitol Hill, and recognition-anchored appearances at ASN Kidney Week.

The Foundation operates a donation-and-sponsorship revenue model without commercial pricing. Income is generated from individual donations processed through NeonCRM, event- and community-led fundraising (including ambassador-hosted restaurant nights), membership enrollment, and corporate sponsorship from pharmaceutical companies developing IgAN therapies—Vertex Pharmaceuticals (Emerald sponsor for Kidney Month 2026), Calliditas Therapeutics (Friend sponsor), Novartis, Vera Therapeutics, and Takeda Pharmaceuticals (Emerging Therapies Forum). Additional programmatic funding has come from the Chan Zuckerberg Initiative, which underwrote the Foundation's first research poster at ASN Kidney Week 2025. No revenue is earned from program participants; all patient-facing services are free of charge.

IgA Nephropathy Foundation firmographics

Firmographics
Name
IgA Nephropathy Foundation
Legal name
IgA Nephropathy Foundation
Website
https://igan.org
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
The IgA Nephropathy Foundation is a 501(c)(3) nonprofit that provides education, support, advocacy, and a global patient registry for individuals affected by IgA Nephropathy, a rare autoimmune kidney disease, and their caregivers.
Ownership category
akta.pro rank

IgA Nephropathy Foundation industry classification

Industry
Product category
Rare Disease Patient Advocacy
NAICS
Voluntary Health Organizations (813212), Other Individual and Family Services (624190)
SIC
Services-Social Services (8300)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

Keywords

  • Rare disease advocacy
  • Kidney disease support
  • Patient education resources
  • Nephrology community programs
  • Patient registry research

Where IgA Nephropathy Foundation is headquartered

Location

Headquarters

HQ city
Township Of Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

IgA Nephropathy Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

  1. Donations and Fundraising: The Foundation generates revenue primarily through donations from individuals, corporate sponsors, and fundraising campaigns. This includes direct donations via its website portal (igan.app.neoncrm.com), event-based fundraising, and community-driven initiatives such as restaurant fundraisers hosted by patient ambassadors.
  2. Corporate Sponsorship: Pharmaceutical companies and healthcare organizations sponsor Foundation programs, events, and campaigns. Sponsorship tiers include Emerald, Friend, and other levels. Sponsors include Vertex Pharmaceuticals (Emerald), Calliditas Therapeutics (Friend), Novartis, Vera Therapeutics, and Takeda Pharmaceuticals.
  3. Membership Dues: The Foundation offers membership enrollment, suggesting membership-based support. Membership provides access to resources, community, and advocacy tools.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goPatient Registry access is free for patients

Go-to-market motion1 record

Distribution channels5 records

Marketing channels10 records

IgA Nephropathy Foundation product offering

Product offering

Core offering

The IgA Nephropathy Foundation is a 501(c)(3) nonprofit patient advocacy organization that delivers education, support, research, and advocacy resources to individuals affected by IgA Nephropathy, a rare autoimmune kidney disease. Its offerings include the IgAN Hope Patient Registry, the IgAN+ mobile app, the SPARK annual conference, the IgAN Care provider finder, nutrition and recipe resources, ambassador and caregiver programs, and federal legislative advocacy. All programs are provided free of charge to patients and caregivers and funded primarily through donations and corporate sponsorships.

Product overview

The IgA Nephropathy Foundation offers a portfolio of patient-focused programs and resources organized around four pillars: education, support, research, and advocacy. The central product is the IgAN Hope Patient Registry—a global database enabling patients with IgA Nephropathy and IgA Vasculitis to contribute health data, connect Electronic Health Records, and support research acceleration. This connects to the Foundation's digital ecosystem: the IgAN+ mobile app (iOS/Android) for patient self-management, the IgAN Cookbook and recipe library for kidney-friendly nutrition, the IgAN Care nephrology provider finder, and the IgAN Risk Quiz for awareness. Community and advocacy are served through the IgAN Ambassador Program, the IgAN Go Global Network for international reach, the annual SPARK Conference for patient education, IgA Nephropathy Day and Kidney Health + Nutrition Month awareness campaigns, and a Patient Aid financial assistance program. Research infrastructure includes a Clinical Trials Directory, an HCP Library for healthcare professional education, and published research articles. The portfolio is completed by Faces of IgAN storytelling, mental health resources, pregnancy and family planning guides, caregiver support, and an IgAN FAQ.

Differentiator

Problem solved

Functional benefit

Brands

  • IgAN Hope Patient Registry: A global registry for individuals with IgA Nephropathy and IgA Vasculitis to drive research, accelerate treatments, and improve patient outcomes.
  • IgAN Go Global Network
  • SPARK Conference
  • IgAN+ App
  • IgAN Ambassador Program

Products and services

  • IgAN Hope Patient Registry A global, HIPAA-compliant patient registry for individuals with IgA Nephropathy and IgA Vasculitis. Participants contribute anonymized health data including diagnosis, symptoms, treatments, lab values, quality of life, diet, and mental health information, and can connect their Electronic Health Record. The registry drives research and accelerates treatment development.
  • IgAN+ Mobile App Mobile application for IgAN patients providing nutrition guides, kidney-friendly recipes, self-management tools, and community resources. Available on iOS and Android via the Foundation's app pages.
  • SPARK Conference The only conference dedicated exclusively to IgA Nephropathy patients and their caregivers, featuring education, research updates, and community connection. Annual event with registration managed through the dedicated SPARK website.
  • IgANCare Provider Finder A nephrology provider finder that allows IgAN patients to locate healthcare providers specialized in their disease. Patients can also encourage their provider to join or nominate a provider for inclusion in the network.
  • IgAN Cookbook Kidney-friendly recipe collection providing meals tailored for individuals managing IgA Nephropathy, with emphasis on low-sodium, low-potassium, and kidney-healthy ingredients. Developed in partnership with Cukebook (Culinary Nutrition for Kidneys, Inc.).
  • IgAN Risk Quiz

Quantifiable outcome

  • 20-40% of IgAN patients develop end-stage kidney disease requiring dialysis or transplant
  • +2 more outcomes

Companies that use IgA Nephropathy Foundation

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles4 records

IgA Nephropathy Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

IgA Nephropathy Foundation partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor and major.

  • Pittsburgh SteelersminorGTM or Marketing Partner · 1 December 2025The Pittsburgh Steelers partnered with the IgAN Foundation and Hayden Shock (kidney transplant recipient) to support the '13 for LIFE' organ donation awareness campaign on Capitol Hill, raising awareness about the organ shortage affecting over 103,000 people in the U.S.
  • Cukebook (Culinary Nutrition for Kidneys, Inc.)majorStrategic or Co-development PartnerCukebook, a nutrition-forward nonprofit backed by 501c3 Culinary Nutrition for Kidneys, Inc., provides recipes, guides, and nutrition tools for people living with chronic kidney disease. The Foundation's recipe section and nutrition content extensively features Cukebook resources, with Lauren Levy serving as both a Foundation contributor and Director at Cukebook.
  • American Society of Nephrology (ASN)majorStrategic or Co-development PartnerASN hosts Kidney Week, at which the Foundation presents research, delivers lectureships, and hosts forums. The Foundation's Bonnie Schneider delivered the Celeste Castillo Lee Endowed Lectureship at ASN Kidney Week 2025.
  • Rare Disease DayminorGTM or Marketing PartnerThe Foundation participates in Rare Disease Day (hosted by rarediseases.org) to raise awareness for IgA Nephropathy as a rare kidney disease.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

IgA Nephropathy Foundation competitors and assessment

Company assessment

Direct peers

  • NephCure Kidney International: Rare kidney disease-focused nonprofit historically centered on nephrotic syndrome and FSGS but expanding to include IgAN. Closest direct peer in mission, structure, and patient registry focus.
  • PKD Foundation: Patient advocacy organization for polycystic kidney disease, another rare genetic kidney disease. Closely comparable as a disease-specific kidney nonprofit operating a patient registry, research grants, and conferences.
  • Alport Syndrome Foundation: Rare hereditary kidney disease foundation providing patient education, community support, and research advocacy. Highly comparable small-team, patient-led structure and mission to accelerate treatments for a rare kidney condition.

Broad incumbents

  • National Kidney Foundation: The largest U.S. kidney disease nonprofit, funding research, patient education, and advocacy across all kidney conditions including IgAN. Highly comparable as a patient-advocacy peer but operates at a much broader scale and lacks IgAN-specific focus.
  • American Kidney Fund: National nonprofit providing financial assistance, education, and advocacy for kidney patients. Directly comparable in mission (patient aid, education, advocacy) and overlapping disease scope, though much larger and not IgAN-focused.
  • American Association of Kidney Patients (AAKP): Independent kidney patient organization focused on advocacy, education, and patient engagement across kidney diseases. Comparable as a kidney-specific patient advocacy peer, including Hill Day-style advocacy and patient ambassadorship.
  • National Organization for Rare Disorders (NORD): Umbrella rare disease advocacy organization that supports patient organizations including IgAN-focused foundations. Highly comparable advocacy mission and patient community focus, but operates at a much larger scale across all rare diseases.
  • EveryLife Foundation for Rare Diseases: Rare disease policy and advocacy nonprofit advancing legislative and regulatory issues for rare disease patient communities. Comparable advocacy focus, particularly around federal policy work that complements the IgAN Foundation's Hill Day efforts.

Others

  • CureGN (Cure Glomerulonephropathy Network): Multi-center NIH-funded research consortium studying glomerular diseases including IgAN. Comparable registry/research mission and serves as both a potential research partner and indirect peer for patient data infrastructure.
  • Kidney Health Initiative: Public-private partnership between ASN and FDA focused on kidney disease innovation. Comparable as a research/advocacy ecosystem stakeholder and the Foundation collaborates with it through ASN Kidney Week.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

IgA Nephropathy Foundation social profiles

Digital presence

IgA Nephropathy Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IgA Nephropathy Foundation leadership team

Management profile

Number of profiles

Profiles1 record

IgA Nephropathy Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

IgA Nephropathy Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IgA Nephropathy Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IgA Nephropathy Foundation

What does IgA Nephropathy Foundation do?

The IgA Nephropathy Foundation is a 501(c)(3) nonprofit patient advocacy organization that delivers education, support, research, and advocacy resources to individuals affected by IgA Nephropathy, a rare autoimmune kidney disease. Its offerings include the IgAN Hope Patient Registry, the IgAN+ mobile app, the SPARK annual conference, the IgAN Care provider finder, nutrition and recipe resources, ambassador and caregiver programs, and federal legislative advocacy. All programs are provided free of charge to patients and caregivers and funded primarily through donations and corporate sponsorships.

Is IgA Nephropathy Foundation a public or private company?

IgA Nephropathy Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was IgA Nephropathy Foundation founded?

IgA Nephropathy Foundation was founded in 2006. It employs 11 to 50 people.

Where is IgA Nephropathy Foundation based?

IgA Nephropathy Foundation is headquartered in Township Of Washington, United States, in the North America region.

How does IgA Nephropathy Foundation make money?

Three revenue lines are on record. Donations and Fundraising is the primary driver. The others are corporate Sponsorship and membership Dues.

Who are IgA Nephropathy Foundation's main competitors?

Direct peers on record are NephCure Kidney International, PKD Foundation and Alport Syndrome Foundation. Broad incumbents are National Kidney Foundation, American Kidney Fund, American Association of Kidney Patients (AAKP), National Organization for Rare Disorders (NORD) and EveryLife Foundation for Rare Diseases. Others are CureGN (Cure Glomerulonephropathy Network) and Kidney Health Initiative.

Does IgA Nephropathy Foundation have an API?

No public API is recorded for IgA Nephropathy Foundation.

What industry is IgA Nephropathy Foundation in?

IgA Nephropathy Foundation's product category is Rare Disease Patient Advocacy. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageAmerican Kidney Fund and IgA Nephropathy Foundation Advocate on Capitol Hill for Rare Kidney Disease LegislationThe American Kidney Fund and IgA Nephropathy Foundation, with over 80 advocates, urged lawmakers to support three kidney disease bills on Capitol Hill. The bills aim to improve access to genetic counseling, living donor protections, and earlier diagnosis. Advocates also highlighted the need for better care in rural and underserved communities.FinancialContent Business PageThe American Kidney Fund and IgA Nephropathy Foundation Create New IgA Nephropathy Patient Guidelines (UPDATE)The American Kidney Fund and the IgA Nephropathy Foundation announced the creation of new patient guidelines for IgA nephropathy, based on updated 2025 clinical guidelines from KDIGO. The guidelines provide plain language explanations of the disease, treatment options, and practical guidance for discussing care with healthcare teams, available as a downloadable printable resource in English, Spanish, Korean, and simplified Chinese. The resource is part of AKF's "A Step Ahead of IgA Nephropathy" educational campaign, with funding from pharmaceutical sponsors including Novartis, Otsuka, Travere Therapeutics, Vertex, and Calliditas.GlobeNewswireThe American Kidney Fund and IgA Nephropathy Foundation Create New IgA Nephropathy Patient Guidelines (UPDATE)The American Kidney Fund (AKF) and the IgA Nephropathy Foundation announced the creation of new patient guidelines for IgA nephropathy, adapted from updated KDIGO clinical guidelines, designed to help patients understand and manage their disease. The guidelines include plain language explanations of the condition and treatment options, practical guidance for discussing care with healthcare teams, and are available as a downloadable printable guide in multiple languages. An interactive version is planned for release later this year, with the resource being part of AKF's broader educational campaign to increase awareness of this rare kidney disease.FinancialContent Business PageThe American Kidney Fund and IgA Nephropathy Foundation Create New IgA Nephropathy Patient GuidelinesThe American Kidney Fund and the IgA Nephropathy Foundation have jointly released new patient guidelines for IgA nephropathy, a rare kidney disease. The guidelines are based on updated KDIGO clinical practice guidelines and were developed with input from patient focus groups and clinician review. The resources include plain language explanations of the disease, treatment options, and practical guidance for discussing care with healthcare teams, and are available as free downloadable materials in multiple languages.GlobeNewswireThe American Kidney Fund and IgA Nephropathy Foundation Create New IgA Nephropathy Patient GuidelinesThe American Kidney Fund and IgA Nephropathy Foundation have jointly released new patient guidelines for IgA nephropathy, a rare kidney disease that causes inflammation and reduces kidney function. The guidelines are based on the 2025 KDIGO evidence-based clinical practice guidelines and were developed with patient focus group input and clinician review, offering plain language explanations and practical guidance for discussing treatment options with healthcare teams. The resource is sponsored by pharmaceutical companies including Novartis, Otsuka, Travere Therapeutics, Vertex Pharmaceuticals, and Calliditas Therapeutics, and will be available in English, Spanish, Korean, and simplified Chinese.EIN PresswireIgA Nephropathy Foundation Launches 'Are You IgAN Aware?' PSA CampaignThe IgA Nephropathy Foundation celebrated its 22nd anniversary by launching its first PSA campaign, 'Are You IgAN Aware? ', and hosting 22 Major League Baseball games under 'Strike Out IgAN.' It also received an Amazin' Award at Citi Field and secured IgAN Day proclamations in multiple states and provinces.EIN PresswireIgA Nephropathy Foundation Launches Kidney Month Campaign Elevating Patient Voices and New Education ResourcesThe IgA Nephropathy Foundation launched a Kidney Month campaign in March 2026 focused on patient education and empowerment, unveiling new educational resources including a "Kidney Terms to Know" guide and an animated nutrition tips video. The foundation also celebrated the publication of a peer-reviewed article in Kidney Medicine co-authored by two members of its Medical and Scientific Advisory Board, both of whom are healthcare professionals living with IgA Nephropathy. Emerald sponsor Vertex Pharmaceuticals and Friend sponsor Calliditas Therapeutics provided support for the campaign.EIN PresswireIgAN Foundation, Steelers, and Hayden Shock Unite for '13 for LIFE' AwarenessThe IgA Nephropathy Foundation has partnered with the Pittsburgh Steelers to support Hayden Shock's '13 for LIFE' Challenge, an organ donation awareness campaign that honors the 13 people who die daily while waiting for transplants in the United States. The Steelers accepted the challenge ahead of Super Bowl weekend, bringing national visibility to a movement addressing over 103,000 Americans currently waiting for organ transplants. The foundation also continues its advocacy on Capitol Hill for the bipartisan Living Donor Protection Act.EIN PresswireIgA Nephropathy Foundation Recognized for Leadership and Research Excellence at ASN Kidney Week 2025The IgA Nephropathy Foundation marked a milestone presence at ASN Kidney Week 2025 in Houston, Texas, with its Co-Founder and Executive Director Bonnie Schneider delivering the prestigious Celeste Castillo Lee Endowed Lectureship. The Foundation also presented its first research poster, funded by the Chan Zuckerberg Initiative, examining cultural and structural barriers faced by Asian Americans with IgA Nephropathy. Additionally, the Foundation hosted an Emerging Therapies Forum with support from Takeda Pharmaceuticals, Vera Therapeutics, and Vertex Pharmaceuticals.GlobeNewswireRare Kidney Disease Community Members Join American Kidney Fund and IgA Nephropathy Foundation on Capitol Hill to Champion Key LegislationThe American Kidney Fund and IgA Nephropathy Foundation, with over 50 advocates, met lawmakers on Capitol Hill to support the New Era of Preventing End-Stage Kidney Disease Act and the Living Donor Protection Act. The bills aim to improve rare kidney disease care, increase awareness, and protect living donors from insurance discrimination and work restrictions.